Turbo-Ject G23712Recalls & reported problems

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00827002237124), received between Oct 30, 2019 and Aug 11, 2022 — classified as 1 injury, 3 malfunctions.

The most frequently reported specific device problem is “Fluid/Blood Leak” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

• MalfunctionAug 11, 2022Fluid/Blood Leak; Leak/Splash; Material Separation; Fluid/Blood Leak; Leak/Splash; Material Separation

  IT WAS REPORTED THAT A LEAK WAS DISCOVERED IN A TURBO-JECT® SINGLE LUMEN BEDSIDE POWER-INJECTABLE PICC IN A MALE PEDIATRIC PATIENT. THE PATIENT HAD RIGHT HAND CUBITAL PLACEMENT OF THE PICC LINE. BLEEDING FROM THE LINE WAS LATER SEEN BY THE FATHER OF THE PATIENT. THE LINE WAS THEN CLAMPED AND EXTRACTED. A PERIPHERAL LINE WAS INSERTED AND BLOOD CULTURES WERE DRAWN. ADDITIONAL INFORMATION REGARDING EVENT AND PATIENT DETAILS HAVE BEEN REQUESTED, BUT ARE CURRENTLY UNAVAILABLE.

  Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

  MAUDE report 15213225 ↗
• MalfunctionSep 18, 2020Fluid/Blood Leak; Fluid/Blood Leak

  ADDITIONAL INFORMATION WAS PROVIDED BY THE CUSTOMER ON 22SEP2020. THE CATHETER WAS PLACED IN THE PATIENT'S RIGHT BASILIC VEIN AND WAS SECURED TO THE PATIENT USING THE SECUREMENT DEVICE (STATLOCK) PROVIDED THE SET. ANTIBIOTIC THERAPY WAS DESCRIBED TO BE THE INDICATION FOR PLACEMENT. A COMPETITOR'S TWO-WAY VALVE WAS ATTACHED TO THE HUB OF THE CATHETER. THE CATHETER WAS LOCKED WITH SALINE WHEN NOT IN USE. AN ANTI-TAMPER/ANTI-REFLUX DEVICE WAS NOT ATTACHED TO THE CATHETER. A PARTIAL SEPARATION WAS IDENTIFIED WHEN THE CATHETER WAS BEING FLUSHED BEFORE "ANTIBIOTIC INFUSION (AT THE VERIFICATION STAGE)". THE DEVICE WAS REMOVED BUT NOT REPLACED. ANTIBIOTICS WERE CONTINUED BY MOUTH INSTEAD OF INTRAVENOUSLY.

  Patient problems: No Code Available

  MAUDE report 10553202 ↗
• InjuryJun 15, 2020Material Separation; Material Separation

  NO ADDITIONAL PATIENT/EVENT INFORMATION HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.

  Patient problems: No Code Available

  MAUDE report 10152811 ↗
• MalfunctionOct 30, 2019Fluid/Blood Leak; Fracture; Fluid/Blood Leak; Fracture

  IT WAS REPORTED IN ADDITIONAL INFORMATION RECEIVED ON (B)(6) 2019 THAT THE INDICATION FOR PLACEMENT WAS FOR LONG TERM PERFUSION IN A PEDIATRIC PATIENT. THE DEVICE FAILED DURING THE INJECTION OF DRUGS AFTER BEING IN PLACE FOR 3 DAYS. NO ADDITIONAL STERILIZATION PROCESSES WERE PERFORMED PRIOR TO USE. ANCILLARY DEVICES BEING USED AT THE TIME OF FAILURE WERE A SYRINGE PUSH. THE DEVICE WAS SECURED TO THE PATIENT USING SUTURE POINTS AND TAPE. THE PATIENT WAS BEDRIDDEN. THE FAILURE OCCURRED AT THE JUNCTION OF THE EXTENSION TUBING AND LUER LOCK HUB. THE SEPARATION WAS PARTIAL, AS THE LEAK OF FLUID WAS APPARENT WHEN THE EXTENSION TUBING WAS ARCHED. NO LEAKAGE OCCURRED WHEN THE TUBING WAS "RIGHT." NO DAMAGE TO THE HUB WAS OBSERVED. IT WAS CONFIRMED THAT THE PURPLE HUB FAILED AND THAT THE DEVICE WAS USED CONTINUOUSLY. THERE IS NO OTHER INFORMATION ABOUT THE TYPE OF DRUGS INFUSED THROUGH THE LINE, HOWEVER THE DEVICE WAS FLUSHED WITH SALINE.

  Patient problems: No Code Available; No Consequences Or Impact To Patient

  MAUDE report 9254932 ↗